News
Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and ...
1don MSN
Vadhera's journey to this cosmic milestone reflects decades of dedication to decoding global beauty rituals and translating ...
University of Cincinnati Cancer Center researchers looked billions of years into the past to learn more about the potential ...
President Donald Trump went to Iowa on Thursday to start the countdown to the nation’s 250th Independence Day next year. To ...
Avocado remains from El Gigante illustrate how ancient farmers domesticated crops to adapt to changing environments. The ...
There is reason to hope for "Peace through Agriculture" with Iran, as I saw during my evening in Tehran, writes Kenneth Quinn ...
The Ohio University Heritage College of Osteopathic Medicine announced a name change and refined focus for the Edison Biotechnology Institute. Now called the Institute for Molecular Medicine and Aging ...
In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical industry to China. Though we have long stood as the global leader in ...
Centuries before biotechnology had a name, humans were already practicing it – breeding animals for resilience, fermenting foods and treating pain with plants. Today, that same spirit of discovery ...
Dr. Vinay Prasad, a known critic of both the pharmaceutical industry and the Food and Drug Administration, has been appointed to lead the FDA 's program overseeing vaccines and biotechnology drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results